US Broker Ratings

Organon & Co. (OGN) Stock Analysis: Exploring a 42.71% Upside Potential Amid Healthcare Market Challenges

For investors seeking opportunities in the healthcare sector, Organon & Co. (NYSE: OGN) presents a compelling case with its diversified portfolio in women’s health, biosimilars, and..

CRISPR Therapeutics AG (CRSP) Stock Analysis: Exploring a 44.90% Potential Upside in Gene Editing

CRISPR Therapeutics AG (NASDAQ: CRSP), a pioneering entity in the field of gene editing, represents a compelling opportunity within the biotechnology sector. With its innovative CRISPR/Cas9..

Acadia Healthcare (ACHC) Stock Analysis: Uncovering a Potential 78% Upside with Strong Buy Ratings

Acadia Healthcare Company, Inc. (NASDAQ: ACHC) is capturing the attention of investors, as the company stands at a crucial juncture with significant upside potential. With a..

Scholar Rock Holding Corporation (SRRK): Analyst Consensus Points to 28.7% Potential Upside

Scholar Rock Holding Corporation (NASDAQ: SRRK), a biopharmaceutical company operating within the dynamic biotechnology industry, is capturing investor attention with its promising pipeline and significant potential..

Beam Therapeutics Inc. (BEAM) Stock Analysis: A 108% Upside Potential in the Biotech Arena

Beam Therapeutics Inc. (NASDAQ: BEAM) stands as a compelling figure in the healthcare sector, particularly within the biotechnology industry. With a market capitalization of $2.13 billion,..

Catalyst Pharmaceuticals, Inc. (CPRX) Stock Analysis: A Biotech Gem with 58.58% Potential Upside for Investors

Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX), a prominent player in the biotechnology industry, is drawing attention from investors with its robust revenue growth and impressive analyst ratings...

Progyny, Inc. (PGNY) Stock Analysis: Exploring the 11.84% Upside Potential in Healthcare Plans

Progyny, Inc. (NASDAQ: PGNY) has emerged as a compelling player within the healthcare sector, specifically focusing on the niche of fertility and family building benefits management...

Tarsus Pharmaceuticals, Inc. (TARS) Stock Analysis: A 78% Upside Potential in Biotech

Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) is capturing the attention of savvy investors with a compelling narrative in the biotechnology sector. As a leading player in the..

Alphatec Holdings, Inc. (ATEC) Stock Analysis: A Healthcare Play with 67.9% Upside Potential

Alphatec Holdings, Inc. (NASDAQ: ATEC) stands as a noteworthy player in the healthcare sector, specializing in medical devices that cater to the surgical treatment of spinal..

PTC Therapeutics, Inc. (PTCT) Stock Analysis: A Biotech Powerhouse with a 27% Potential Upside

PTC Therapeutics, Inc. (NASDAQ: PTCT) is capturing investor attention with its promising growth prospects and robust pipeline in the biotechnology sector. With a market capitalization of..

Denali Therapeutics Inc. (DNLI) Stock Analysis: Exploring the 119% Potential Upside Amid Strong Buy Ratings

For investors eyeing opportunities in the biotechnology sector, Denali Therapeutics Inc. (DNLI) presents a compelling case with its innovative approach to treating neurodegenerative diseases. Headquartered in..

Amneal Pharmaceuticals, Inc. (AMRX) Stock Analysis: A 39.55% Potential Upside Beckons Investors

Amneal Pharmaceuticals, Inc. (AMRX), a prominent player in the healthcare sector, is garnering attention from investors due to its substantial potential upside. With a market capitalization..

CG Oncology, Inc. (CGON) Investor Outlook: Analyzing a 132.95% Potential Upside in Biotech

CG Oncology, Inc. (CGON), a prominent player in the biotechnology sector, is capturing investor attention with its compelling potential upside of 132.95%. This late-stage clinical biopharmaceutical..

Sotera Health Company (SHC) Stock Analysis: Navigating a 24.89% Potential Upside in Healthcare

Sotera Health Company (NASDAQ: SHC) stands out in the healthcare sector, particularly in the diagnostics and research industry. With a market capitalization of $3.3 billion, this..

Select Medical Holdings Corp (SEM) Stock Analysis: A 37% Upside Potential with Strong Buy Ratings

Select Medical Holdings Corporation (NYSE: SEM), a prominent player in the healthcare sector, is capturing investor attention not only with its robust market position but also..

Metsera, Inc. (MTSR) Stock Analysis: Exploring a Potential 29.50% Upside in the Biotech Industry

For investors seeking opportunities in the burgeoning field of biotechnology, Metsera, Inc. (NASDAQ: MTSR) presents an intriguing prospect. With its focus on developing innovative treatments for..

Veracyte, Inc. (VCYT) Stock Analysis: Unpacking the 53% Upside Potential

For investors navigating the healthcare sector, Veracyte, Inc. (NASDAQ: VCYT) presents an intriguing case with its robust growth potential and a substantial upside forecasted by analysts...

Surgery Partners, Inc. (SGRY) Stock Analysis: Exploring a 39.58% Potential Upside for Investors

Surgery Partners, Inc. (NASDAQ: SGRY), a prominent player in the healthcare sector specializing in medical care facilities, offers an intriguing investment opportunity. With a market capitalization..

GeneDx Holdings Corp. (WGS) Stock Analysis: Exploring a 25.88% Potential Upside in Genomics Innovation

GeneDx Holdings Corp. (NASDAQ: WGS) is making waves in the healthcare sector, specifically within the diagnostics and research industry. Based in Stamford, Connecticut, GeneDx specializes in..

Concentra Group Holdings Parent (CON) Stock Analysis: A Healthcare Powerhouse with 38% Upside Potential

For investors seeking opportunities in the healthcare sector, Concentra Group Holdings Parent (NASDAQ: CON) emerges as a compelling candidate. With a market capitalization of $2.59 billion,..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds